-
1
-
-
77957325778
-
Novel lipid mediators and resolution mechanisms in acute inflammation: To resolve or not?
-
C. N. Serhan, "Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?" The American Journal of Pathology, Vol. 177, no. 4, pp. 1576-1591, 2010.
-
(2010)
The American Journal of Pathology
, vol.177
, Issue.4
, pp. 1576-1591
-
-
Serhan, C.N.1
-
2
-
-
0036499224
-
Prostaglandins as modulators of immunity
-
S. G. Harris, J. Padilla, L. Koumas, D. Ray, and R. P. Phipps, "Prostaglandins as modulators of immunity," Trends in Immunology, Vol. 23, no. 3, pp. 144-150, 2002.
-
(2002)
Trends in Immunology
, vol.23
, Issue.3
, pp. 144-150
-
-
Harris, S.G.1
Padilla, J.2
Koumas, L.3
Ray, D.4
Phipps, R.P.5
-
3
-
-
0346665524
-
2
-
2," Biochemical Journal, Vol. 365, no. 2, pp. 489-496, 2002.
-
(2002)
Biochemical Journal
, vol.365
, Issue.2
, pp. 489-496
-
-
Levin, G.1
Duffin, K.L.2
Obukowicz, M.G.3
-
4
-
-
34547958615
-
Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products
-
M. Wada, C. J. DeLong, Y. H. Hong et al., "Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products," The Journal of Biological Chemistry, Vol. 282, no. 31, pp. 22254-22266, 2007.
-
(2007)
The Journal of Biological Chemistry
, vol.282
, Issue.31
, pp. 22254-22266
-
-
Wada, M.1
DeLong, C.J.2
Hong, Y.H.3
-
6
-
-
52949153587
-
Arachidonic-acid-derived eicosanoids: Roles in biology and immunopathology
-
H. Harizi, J.-B. Corcuff, and N. Gualde, "Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology," Trends in Molecular Medicine, Vol. 14, no. 10, pp. 461-469, 2008.
-
(2008)
Trends in Molecular Medicine
, vol.14
, Issue.10
, pp. 461-469
-
-
Harizi, H.1
Corcuff, J.-B.2
Gualde, N.3
-
7
-
-
84891892143
-
The role of pro-resolution lipid mediators in infectious disease
-
C. D. Russell and J. Schwarze, "The role of pro-resolution lipid mediators in infectious disease," Immunology, Vol. 141, no. 2, pp. 166-173, 2013.
-
(2013)
Immunology
, vol.141
, Issue.2
, pp. 166-173
-
-
Russell, C.D.1
Schwarze, J.2
-
8
-
-
34249110684
-
Roles of lipid mediators in kidney injury
-
C.-M. Hao and M. D. Breyer, "Roles of lipid mediators in kidney injury," Seminars in Nephrology, Vol. 27, no. 3, pp. 338-351, 2007.
-
(2007)
Seminars in Nephrology
, vol.27
, Issue.3
, pp. 338-351
-
-
Hao, C.-M.1
Breyer, M.D.2
-
9
-
-
84890806672
-
Inhibitors of the arachidonic acid cascade: Interfering with multiple pathways
-
K. Meirer, D. Steinhilber, and E. Proschak, "Inhibitors of the arachidonic acid cascade: interfering with multiple pathways," Basic and Clinical Pharmacology and Toxicology, Vol. 114, no. 1, pp. 83-91, 2014.
-
(2014)
Basic and Clinical Pharmacology and Toxicology
, vol.114
, Issue.1
, pp. 83-91
-
-
Meirer, K.1
Steinhilber, D.2
Proschak, E.3
-
10
-
-
38449089938
-
Diabetic complications and dysregulated innate immunity
-
D. T. Graves and R. A. Kayal, "Diabetic complications and dysregulated innate immunity," Frontiers in Bioscience, Vol. 13, no. 4, pp. 1227-1239, 2008.
-
(2008)
Frontiers in Bioscience
, vol.13
, Issue.4
, pp. 1227-1239
-
-
Graves, D.T.1
Kayal, R.A.2
-
12
-
-
77951089891
-
-
International Diabetes Federation, Brussels, Belgium, 6th edition
-
International Diabetes Federation, IDF Diabetes Atlas, International Diabetes Federation, Brussels, Belgium, 6th edition, 2013, http://www.idf.org/diabetesatlas.
-
(2013)
IDF Diabetes Atlas
-
-
-
13
-
-
0041315638
-
The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: Role of glycemic control
-
F. Cipollone, A. Iezzi, M. Fazia et al., "The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control," Circulation, Vol. 108, no. 9, pp. 1070-1077, 2003.
-
(2003)
Circulation
, vol.108
, Issue.9
, pp. 1070-1077
-
-
Cipollone, F.1
Iezzi, A.2
Fazia, M.3
-
14
-
-
0027131144
-
2 actions in rat hepatocytes are mediated via different signalling pathways
-
2 actions in rat hepatocytes are mediated via different signalling pathways," European Journal of Biochemistry, Vol. 218, no. 3, pp. 1083-1089, 1993.
-
(1993)
European Journal of Biochemistry
, vol.218
, Issue.3
, pp. 1083-1089
-
-
Puschel, G.P.1
Kirchner, C.2
Schroder, A.3
Jungermann, K.4
-
15
-
-
70349241726
-
Aggravation by prostaglandin E2 of interleukin-6-dependent insulin resistance in hepatocytes
-
J. Henkel, F. Neuschäfer-Rube, A. Pathe-Neuschäfer-Rube, and G. P. Püschel, "Aggravation by prostaglandin E2 of interleukin-6-dependent insulin resistance in hepatocytes," Hepatology, Vol. 50, no. 3, pp. 781-790, 2009.
-
(2009)
Hepatology
, vol.50
, Issue.3
, pp. 781-790
-
-
Henkel, J.1
Neuschäfer-Rube, F.2
Pathe-Neuschäfer-Rube, A.3
Püschel, G.P.4
-
16
-
-
33847025363
-
The role of 12/15-lipoxygenase in the expression of interleukin-6 and tumor necrosis factor-α in macrophages
-
Y. Wen, J. Gu, S. K. Chakrabarti et al., "The role of 12/15-lipoxygenase in the expression of interleukin-6 and tumor necrosis factor-α in macrophages," Endocrinology, Vol. 148, no. 3, pp. 1313-1322, 2007.
-
(2007)
Endocrinology
, vol.148
, Issue.3
, pp. 1313-1322
-
-
Wen, Y.1
Gu, J.2
Chakrabarti, S.K.3
-
17
-
-
41749097860
-
Role of 12/15-lipoxygenase in the expression of MCP-1 in mouse macrophages
-
Y. Wen, J. Gu, G. E. Vandenhoff, X. Liu, and J. L. Nadler, "Role of 12/15-lipoxygenase in the expression of MCP-1 in mouse macrophages," The American Journal of Physiology - Heart and Circulatory Physiology, Vol. 294, no. 4, pp. H1933-H1938, 2008.
-
(2008)
The American Journal of Physiology - Heart and Circulatory Physiology
, vol.294
, Issue.4
, pp. H1933-H1938
-
-
Wen, Y.1
Gu, J.2
Vandenhoff, G.E.3
Liu, X.4
Nadler, J.L.5
-
18
-
-
69749102190
-
12/15-Lipoxygenase products induce inflammation and impair insulin signaling in 3t3-l1 adipocytes
-
S. K. Chakrabarti, B. K. Cole, Y. Wen, S. R. Keller, and J. L. Nadler, "12/15-Lipoxygenase products induce inflammation and impair insulin signaling in 3t3-l1 adipocytes," Obesity, Vol. 17, no. 9, pp. 1657-1663, 2009.
-
(2009)
Obesity
, vol.17
, Issue.9
, pp. 1657-1663
-
-
Chakrabarti, S.K.1
Cole, B.K.2
Wen, Y.3
Keller, S.R.4
Nadler, J.L.5
-
19
-
-
0036499692
-
A natural protective mechanism against hyperglycaemia in vascular endothelial and smooth-muscle cells: Role of glucose and 12-hydroxyeicosatetraenoic acid
-
E. Alpert, A. Gruzman, H. Totary, N. Kaiser, R. Reich, and S. Sasson, "A natural protective mechanism against hyperglycaemia in vascular endothelial and smooth-muscle cells: role of glucose and 12-hydroxyeicosatetraenoic acid," Biochemical Journal, Vol. 362, part 2, pp. 413-422, 2002.
-
(2002)
Biochemical Journal
, vol.362
, pp. 413-422
-
-
Alpert, E.1
Gruzman, A.2
Totary, H.3
Kaiser, N.4
Reich, R.5
Sasson, S.6
-
20
-
-
0035195308
-
Hypoglycaemia and hypothermia due to nimesulide overdose
-
E. Yapakçi, O. Uysal, H. Demirbilek, S. Olgar, N. Naçar, and H. Özen, "Hypoglycaemia and hypothermia due to nimesulide overdose," Archives of Disease in Childhood, Vol. 85, no. 6, p. 510, 2001.
-
(2001)
Archives of Disease in Childhood
, vol.85
, Issue.6
, pp. 510
-
-
Yapakçi, E.1
Uysal, O.2
Demirbilek, H.3
Olgar, S.4
Naçar, N.5
Özen, H.6
-
21
-
-
74949127867
-
Cyclooxygenase 2 inhibition exacerbates palmitate-induced inflammation and insulin resistance in skeletal muscle cells
-
T. Coll, X. Palomer, F. Blanco-Vaca et al., "Cyclooxygenase 2 inhibition exacerbates palmitate-induced inflammation and insulin resistance in skeletal muscle cells," Endocrinology, Vol. 151, no. 2, pp. 537-548, 2010.
-
(2010)
Endocrinology
, vol.151
, Issue.2
, pp. 537-548
-
-
Coll, T.1
Palomer, X.2
Blanco-Vaca, F.3
-
22
-
-
33845782864
-
Diabetes: Changing the fate of diabetics in the dialysis unit
-
B. Broumand, "Diabetes: changing the fate of diabetics in the dialysis unit," Blood Purification, Vol. 25, no. 1, pp. 39-47, 2006.
-
(2006)
Blood Purification
, vol.25
, Issue.1
, pp. 39-47
-
-
Broumand, B.1
-
23
-
-
0031985190
-
Diabetic nephropathy
-
M. E. Molitch, R. A. DeFronzo, M. J. Franz et al., "Diabetic nephropathy," Diabetes Care, Vol. 21, no. 1, pp. S50-S53, 1998.
-
(1998)
Diabetes Care
, vol.21
, Issue.1
, pp. S50-S53
-
-
Molitch, M.E.1
DeFronzo, R.A.2
Franz, M.J.3
-
24
-
-
0030047930
-
Functional and molecular aspects of renal prostaglandin receptors
-
M. D. Breyer, H. R. Jacobson, and R. M. Breyer, "Functional and molecular aspects of renal prostaglandin receptors," Journal of the American Society of Nephrology, Vol. 7, no. 1, pp. 8-17, 1996.
-
(1996)
Journal of the American Society of Nephrology
, vol.7
, Issue.1
, pp. 8-17
-
-
Breyer, M.D.1
Jacobson, H.R.2
Breyer, R.M.3
-
25
-
-
0033988783
-
Prostaglandin receptors: Their role in regulating renal function
-
M. D. Breyer and R. M. Breyer, "Prostaglandin receptors: their role in regulating renal function," Current Opinion in Nephrology and Hypertension, Vol. 9, no. 1, pp. 23-29, 2000.
-
(2000)
Current Opinion in Nephrology and Hypertension
, vol.9
, Issue.1
, pp. 23-29
-
-
Breyer, M.D.1
Breyer, R.M.2
-
26
-
-
0034989055
-
2 EP2 and EP4 receptors in the rat kidney
-
2 EP2 and EP4 receptors in the rat kidney," American Journal of Physiology - Renal Physiology, Vol. 280, no. 6, pp. F1001-F1009, 2001.
-
(2001)
American Journal of Physiology - Renal Physiology
, vol.280
, Issue.6
, pp. F1001-F1009
-
-
Jensen, B.L.1
Stubbe, J.2
Hansen, P.B.3
Andreasen, D.4
Skøtt, O.5
-
27
-
-
84866122642
-
Inflammation in diabetic nephropathy
-
A. K. H. Lim and G. H. Tesch, "Inflammation in diabetic nephropathy," Mediators of Inflammation, Vol. 2012, Article ID 146154, 12 pages, 2012.
-
(2012)
Mediators of Inflammation
, vol.2012
-
-
Lim, A.K.H.1
Tesch, G.H.2
-
28
-
-
84878371278
-
Microinflammation in the pathogenesis of diabetic nephropathy
-
K. Shikata and H. Makino, "Microinflammation in the pathogenesis of diabetic nephropathy," Journal of Diabetes Investigation, Vol. 4, no. 2, pp. 142-149, 2013.
-
(2013)
Journal of Diabetes Investigation
, vol.4
, Issue.2
, pp. 142-149
-
-
Shikata, K.1
Makino, H.2
-
29
-
-
0346101486
-
Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury
-
F. Chow, E. Ozols, D. J. Nikolic-Paterson, R. C. Atkins, and G. H. Tesch, "Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury," Kidney International, Vol. 65, no. 1, pp. 116-128, 2004.
-
(2004)
Kidney International
, vol.65
, Issue.1
, pp. 116-128
-
-
Chow, F.1
Ozols, E.2
Nikolic-Paterson, D.J.3
Atkins, R.C.4
Tesch, G.H.5
-
30
-
-
33845893315
-
Elevation of pro-inflammatory cytokines, C-reactive protein and cardiac troponin T in chronic renal failure patients on dialysis
-
C. K. Wong, C. C. Szeto, M. H. M. Chan, C. B. Leung, P. K. T. Li, and C.W.K. Lam, "Elevation of pro-inflammatory cytokines, C-reactive protein and cardiac troponin T in chronic renal failure patients on dialysis," Immunological Investigations, Vol. 36, no. 1, pp. 47-57, 2007.
-
(2007)
Immunological Investigations
, vol.36
, Issue.1
, pp. 47-57
-
-
Wong, C.K.1
Szeto, C.C.2
Chan, M.H.M.3
Leung, C.B.4
Li, P.K.T.5
Lam, C.W.K.6
-
31
-
-
33645454310
-
Leukocyte recruitment and vascular injury in diabetic nephropathy
-
E. Galkina and K. Ley, "Leukocyte recruitment and vascular injury in diabetic nephropathy," Journal of the American Society of Nephrology, Vol. 17, no. 2, pp. 368-377, 2006.
-
(2006)
Journal of the American Society of Nephrology
, vol.17
, Issue.2
, pp. 368-377
-
-
Galkina, E.1
Ley, K.2
-
32
-
-
0024514535
-
Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat renal mesangial cells
-
J. Pfeilschifter, W. Pignat, K. Vosbeck, and F. Marki, "Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat renal mesangial cells," Biochemical and Biophysical Research Communications, Vol. 159, no. 2, pp. 385-394, 1989.
-
(1989)
Biochemical and Biophysical Research Communications
, vol.159
, Issue.2
, pp. 385-394
-
-
Pfeilschifter, J.1
Pignat, W.2
Vosbeck, K.3
Marki, F.4
-
33
-
-
37549014947
-
2 inhibits tumor necrosis factor-alpha RNA through PKA type I
-
2 inhibits tumor necrosis factor-alpha RNA through PKA type I," Biochemical and Biophysical Research Communications, Vol. 366, no. 1, pp. 104-109, 2008.
-
(2008)
Biochemical and Biophysical Research Communications
, vol.366
, Issue.1
, pp. 104-109
-
-
Stafford, J.B.1
Marnett, L.J.2
-
34
-
-
17044447324
-
2: Studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists
-
2: studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists," Biochemical Pharmacology, Vol. 61, no. 9, pp. 1153-1160, 2001.
-
(2001)
Biochemical Pharmacology
, vol.61
, Issue.9
, pp. 1153-1160
-
-
Shinomiya, S.1
Naraba, H.2
Ueno, A.3
-
35
-
-
36148978529
-
Cyclooxygenases, prostanoids, and tumor progression
-
M.-T. Wang, K. V. Honn, and D. Nie, "Cyclooxygenases, prostanoids, and tumor progression," Cancer and Metastasis Reviews, Vol. 26, no. 3-4, pp. 525-534, 2007.
-
(2007)
Cancer and Metastasis Reviews
, vol.26
, Issue.3-4
, pp. 525-534
-
-
Wang, M.-T.1
Honn, K.V.2
Nie, D.3
-
36
-
-
0035383783
-
Prostaglandin E2 is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer
-
P. Kaliriski, P. L. Vieira, J. H. N. Schuitemaker, E. C. de Jong, and M. L. Kapsenberg, "Prostaglandin E2 is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer," Blood, Vol. 97, no. 11, pp. 3466-3469, 2001.
-
(2001)
Blood
, vol.97
, Issue.11
, pp. 3466-3469
-
-
Kaliriski, P.1
Vieira, P.L.2
Schuitemaker, J.H.N.3
De Jong, E.C.4
Kapsenberg, M.L.5
-
37
-
-
0036498542
-
Cyclooxygenase-2-issued prostaglandin E2 enhances the production of endogenous IL-10, which down-regulates dendritic cell functions
-
H. Harizi, M. Juzan, V. Pitard, J. F. Moreau, and N. Gualde, "Cyclooxygenase-2-issued prostaglandin E2 enhances the production of endogenous IL-10, which down-regulates dendritic cell functions," Journal of Immunology, Vol. 168, no. 5, pp. 2255-2263, 2002.
-
(2002)
Journal of Immunology
, vol.168
, Issue.5
, pp. 2255-2263
-
-
Harizi, H.1
Juzan, M.2
Pitard, V.3
Moreau, J.F.4
Gualde, N.5
-
38
-
-
26944433131
-
Linking metabolism and immunology: Diabetic nephropathy is an inflammatory disease
-
K. R. Tuttle, "Linking metabolism and immunology: diabetic nephropathy is an inflammatory disease," Journal of the American Society of Nephrology, Vol. 16, no. 6, pp. 1537-1538, 2005.
-
(2005)
Journal of the American Society of Nephrology
, vol.16
, Issue.6
, pp. 1537-1538
-
-
Tuttle, K.R.1
-
39
-
-
33845405589
-
Inflammation and diabetic nephropathy
-
C. Mora and J. F. Navarro, "Inflammation and diabetic nephropathy," Current Diabetes Reports, Vol. 6, no. 6, pp. 463-468, 2006.
-
(2006)
Current Diabetes Reports
, vol.6
, Issue.6
, pp. 463-468
-
-
Mora, C.1
Navarro, J.F.2
-
40
-
-
33845866857
-
Inflammation and metabolic disorders
-
G. S. Hotamisligil, "Inflammation and metabolic disorders," Nature, Vol. 444, no. 7121, pp. 860-867, 2006.
-
(2006)
Nature
, vol.444
, Issue.7121
, pp. 860-867
-
-
Hotamisligil, G.S.1
-
41
-
-
79960134417
-
Podocyte COX-2 exacerbates diabetic nephropathybyincreasing podocyte (pro)renin receptor expression
-
H. Cheng, X. Fan, G. W. Moeckel, and R. C. Harris, "Podocyte COX-2 exacerbates diabetic nephropathybyincreasing podocyte (pro)renin receptor expression," Journal of the American Society of Nephrology, Vol. 22, no. 7, pp. 1240-1251, 2011.
-
(2011)
Journal of the American Society of Nephrology
, vol.22
, Issue.7
, pp. 1240-1251
-
-
Cheng, H.1
Fan, X.2
Moeckel, G.W.3
Harris, R.C.4
-
42
-
-
77955376918
-
Prevalence of diabetic retinopathy in the United States, 2005-2008
-
X. Zhang, J. B. Saaddine, C.-F. Chou et al., "Prevalence of diabetic retinopathy in the United States, 2005-2008," The Journal of the American Medical Association, Vol. 304, no. 6, pp. 649-656, 2010.
-
(2010)
The Journal of the American Medical Association
, vol.304
, Issue.6
, pp. 649-656
-
-
Zhang, X.1
Saaddine, J.B.2
Chou, C.-F.3
-
43
-
-
7044228789
-
A central role for inflammation in the pathogenesis of diabetic retinopathy
-
A. M. Joussen, V. Poulaki, M. L. Le et al., "A central role for inflammation in the pathogenesis of diabetic retinopathy," The FASEB Jour nal, Vol. 18, no. 12, pp. 1450-1452, 2004.
-
(2004)
The FASEB Jour Nal
, vol.18
, Issue.12
, pp. 1450-1452
-
-
Joussen, A.M.1
Poulaki, V.2
Le, M.L.3
-
44
-
-
77449154762
-
Remodeling of retinal fatty acids in an animal model of diabetes: A decrease in long-chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4
-
M. Tikhonenko, T. A. Lydic, Y. Wang et al., "Remodeling of retinal fatty acids in an animal model of diabetes: a decrease in long-chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4," Diabetes, Vol. 59, no. 1, pp. 219-227, 2010.
-
(2010)
Diabetes
, vol.59
, Issue.1
, pp. 219-227
-
-
Tikhonenko, M.1
Lydic, T.A.2
Wang, Y.3
-
45
-
-
55449103992
-
Expression of cyclo-oxygenase-2 and downstream enzymes in diabetic fibrovascular epiretinal membranes
-
A. M. Abu El-Asrar, L. Missotten, and K. Geboes, "Expression of cyclo-oxygenase-2 and downstream enzymes in diabetic fibrovascular epiretinal membranes," British Journal of Ophthalmology, Vol. 92, no. 11, pp. 1534-1539, 2008.
-
(2008)
British Journal of Ophthalmology
, vol.92
, Issue.11
, pp. 1534-1539
-
-
Abu El-Asrar, A.M.1
Missotten, L.2
Geboes, K.3
-
46
-
-
77954264059
-
Profile of lipid and protein autacoids in diabetic vitreous correlates with the progression of diabetic retinopathy
-
M. L. Schwartzman, P. Iserovich, K. Gotlinger et al., "Profile of lipid and protein autacoids in diabetic vitreous correlates with the progression of diabetic retinopathy," Diabetes, Vol. 59, no. 7, pp. 1780-1788, 2010.
-
(2010)
Diabetes
, vol.59
, Issue.7
, pp. 1780-1788
-
-
Schwartzman, M.L.1
Iserovich, P.2
Gotlinger, K.3
-
47
-
-
0027945466
-
Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene
-
X.-S. Chen, J. R. Sheller, E. N. Johnson, and C. D. Funk, "Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene," Nature, Vol. 372, no. 6502, pp. 179-182, 1994.
-
(1994)
Nature
, vol.372
, Issue.6502
, pp. 179-182
-
-
Chen, X.-S.1
Sheller, J.R.2
Johnson, E.N.3
Funk, C.D.4
-
48
-
-
0034057240
-
5-Lipoxygenase and leukotrienes: Transgenic mouse and nuclear targeting studies
-
C. D. Funk and X.-S. Chen, "5-Lipoxygenase and leukotrienes: transgenic mouse and nuclear targeting studies," American Journal of Respiratory and Critical Care Medicine, Vol. 161, no. 2, pp. S120-S124, 2000.
-
(2000)
American Journal of Respiratory and Critical Care Medicine
, vol.161
, Issue.2
, pp. S120-S124
-
-
Funk, C.D.1
Chen, X.-S.2
-
49
-
-
79960190061
-
Inflammation in diabetic retinopathy
-
J. Tang and T. S. Kern, "Inflammation in diabetic retinopathy," Progress in Retinal and Eye Research, Vol. 30, no. 5, pp. 343-358, 2011.
-
(2011)
Progress in Retinal and Eye Research
, vol.30
, Issue.5
, pp. 343-358
-
-
Tang, J.1
Kern, T.S.2
-
50
-
-
48449097142
-
5-Lipoxygenase, but not 12/15-lipoxygenase, contributes to degeneration of retinal capillaries in a mouse model of diabetic retinopathy
-
R. A. Gubitosi-Klug, R. Talahalli, Y. Du, J. L. Nadler, and T. S. Kern, "5-Lipoxygenase, but not 12/15-lipoxygenase, contributes to degeneration of retinal capillaries in a mouse model of diabetic retinopathy," Diabetes, Vol. 57, no. 5, pp. 1387-1393, 2008.
-
(2008)
Diabetes
, vol.57
, Issue.5
, pp. 1387-1393
-
-
Gubitosi-Klug, R.A.1
Talahalli, R.2
Du, Y.3
Nadler, J.L.4
Kern, T.S.5
-
51
-
-
41149099068
-
Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy
-
T. S. Kern, "Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy," Experimental Diabetes Research, Vol. 2007, p. 95103, 2007.
-
(2007)
Experimental Diabetes Research
, vol.2007
, pp. 95103
-
-
Kern, T.S.1
-
52
-
-
77949900429
-
Increased synthesis of leukotrienes in the mouse model of diabetic retinopathy
-
R. Talahalli, S. Zarini, N. Sheibani, R. C. Murphy, and R. A. Gubitosi-Klug, "Increased synthesis of leukotrienes in the mouse model of diabetic retinopathy," Investigative Ophthalmology and Visual Science, Vol. 51, no. 3, pp. 1699-1708, 2010.
-
(2010)
Investigative Ophthalmology and Visual Science
, vol.51
, Issue.3
, pp. 1699-1708
-
-
Talahalli, R.1
Zarini, S.2
Sheibani, N.3
Murphy, R.C.4
Gubitosi-Klug, R.A.5
-
53
-
-
84871998547
-
Leukocytes regulate retinal capillary degeneration in the diabetic mouse via generation of leukotrienes
-
R. Talahalli, S. Zarini, J. Tang et al., "Leukocytes regulate retinal capillary degeneration in the diabetic mouse via generation of leukotrienes," Journal of Leukocyte Biology, Vol. 93, no. 1, pp. 135-143, 2013.
-
(2013)
Journal of Leukocyte Biology
, vol.93
, Issue.1
, pp. 135-143
-
-
Talahalli, R.1
Zarini, S.2
Tang, J.3
-
54
-
-
22144469481
-
Management of diabetic peripheral neuropathy
-
A. J. M. Boulton, "Management of diabetic peripheral neuropathy," Clinical Diabetes, Vol. 23, no. 1, pp. 9-15, 2005.
-
(2005)
Clinical Diabetes
, vol.23
, Issue.1
, pp. 9-15
-
-
Boulton, A.J.M.1
-
55
-
-
84861111124
-
Diabetic neuropathy: Clinical manifestations and current treatments
-
B. C. Callaghan, H. T. Cheng, C. L. Stables, A. L. Smith, and E. L. Feldman, "Diabetic neuropathy: clinical manifestations and current treatments," The Lancet Neurology, Vol. 11, no. 6, pp. 521-534, 2012.
-
(2012)
The Lancet Neurology
, vol.11
, Issue.6
, pp. 521-534
-
-
Callaghan, B.C.1
Cheng, H.T.2
Stables, C.L.3
Smith, A.L.4
Feldman, E.L.5
-
56
-
-
78651101592
-
Diabetic neuropathies: Update on definitions, diagnostic criteria, estimation of severity, and treatment
-
S. Tesfaye, A. J. Boulton, P. J. Dyck et al., "Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatment," Diabetes Care, Vol. 33, no. 10, pp. 2285-2293, 2010.
-
(2010)
Diabetes Care
, vol.33
, Issue.10
, pp. 2285-2293
-
-
Tesfaye, S.1
Boulton, A.J.2
Dyck, P.J.3
-
57
-
-
33751415845
-
Intrathecally administered COX-2 but not COX-1 or COX-3 inhibitors attenuate streptozotocin-induced mechanical hyperalgesia in rats
-
A. Matsunaga, M. Kawamoto, S. Shiraishi et al., "Intrathecally administered COX-2 but not COX-1 or COX-3 inhibitors attenuate streptozotocin-induced mechanical hyperalgesia in rats," European Journal of Pharmacology, Vol. 554, no. 1, pp. 12-17, 2007.
-
(2007)
European Journal of Pharmacology
, vol.554
, Issue.1
, pp. 12-17
-
-
Matsunaga, A.1
Kawamoto, M.2
Shiraishi, S.3
-
58
-
-
0035976575
-
Prostaglandins and leukotrienes: Advances in eicosanoid biology
-
C. D. Funk, "Prostaglandins and leukotrienes: advances in eicosanoid biology," Science, Vol. 294, no. 5548, pp. 1871-1875, 2001.
-
(2001)
Science
, vol.294
, Issue.5548
, pp. 1871-1875
-
-
Funk, C.D.1
-
59
-
-
23644439784
-
Vascular complications in diabetes mellitus: The role of endothelial dysfunction
-
C. G. Schalkwijk and C. D. A. Stehouwer, "Vascular complications in diabetes mellitus: the role of endothelial dysfunction," Clinical Science, Vol. 109, no. 2, pp. 143-159, 2005.
-
(2005)
Clinical Science
, vol.109
, Issue.2
, pp. 143-159
-
-
Schalkwijk, C.G.1
Stehouwer, C.D.A.2
-
60
-
-
84868640465
-
Basal insulin and cardiovascular and other outcomes
-
A. Ceriello, "Basal insulin and cardiovascular and other outcomes," The New England Journal of Medicine, Vol. 367, no. 18, pp. 1762-1763, 2012.
-
(2012)
The New England Journal of Medicine
, vol.367
, Issue.18
, pp. 1762-1763
-
-
Ceriello, A.1
-
61
-
-
22744447320
-
COX-2 Up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice
-
Z. Guo, W. Su, S. Allen et al., "COX-2 Up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice," Cardiovascular Research, Vol. 67, no. 4, pp. 723-735, 2005.
-
(2005)
Cardiovascular Research
, vol.67
, Issue.4
, pp. 723-735
-
-
Guo, Z.1
Su, W.2
Allen, S.3
-
62
-
-
33748340627
-
Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus
-
T. Szerafin, N. Erdei, T. Fülöp et al., "Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus," Circulation Research, Vol. 99, no. 5, pp. e12-e17, 2006.
-
(2006)
Circulation Research
, vol.99
, Issue.5
, pp. e12-e17
-
-
Szerafin, T.1
Erdei, N.2
Fülöp, T.3
-
63
-
-
84904251841
-
Effects of nimesulide, a selective COX-2 inhibitor, on cardiovascular function in two rat models of diabetes
-
J. Y. T. Leung and C. C. Y. Pang, "Effects of nimesulide, a selective COX-2 inhibitor, on cardiovascular function in two rat models of diabetes," Journal of Cardiovascular Pharmacology, Vol. 64, no. 1, pp. 79-86, 2014.
-
(2014)
Journal of Cardiovascular Pharmacology
, vol.64
, Issue.1
, pp. 79-86
-
-
Leung, J.Y.T.1
Pang, C.C.Y.2
-
64
-
-
63449127321
-
Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling
-
K. Boniface, K. S. Bak-Jensen, Y. Li et al., "Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling," The Journal of Experimental Medicine, Vol. 206, no. 3, pp. 535-548, 2009.
-
(2009)
The Journal of Experimental Medicine
, vol.206
, Issue.3
, pp. 535-548
-
-
Boniface, K.1
Bak-Jensen, K.S.2
Li, Y.3
-
65
-
-
0032173437
-
2 stimulates IL-8 gene expression in human colonic epithelial cells by a posttranscriptional mechanism
-
2 stimulates IL-8 gene expression in human colonic epithelial cells by a posttranscriptional mechanism," The Journal of Immunology, Vol. 161, no. 7, pp. 3746-3752, 1998.
-
(1998)
The Journal of Immunology
, vol.161
, Issue.7
, pp. 3746-3752
-
-
Yu, Y.1
Chadee, K.2
-
66
-
-
30144436343
-
Prostaglandin E2 promotes degranulation-independent release of MCP-1 from mast cells
-
T. Nakayama, N. Mutsuga, L. Yao, and G. Tosato, "Prostaglandin E2 promotes degranulation-independent release of MCP-1 from mast cells," Journal of Leukocyte Biology, Vol. 79, no. 1, pp. 95-104, 2006.
-
(2006)
Journal of Leukocyte Biology
, vol.79
, Issue.1
, pp. 95-104
-
-
Nakayama, T.1
Mutsuga, N.2
Yao, L.3
Tosato, G.4
-
67
-
-
33644695015
-
Prostaglandin E2 potentiates the immunologically stimulated histamine release from human peripheral blood-derived mast cells through EP1/EP3 receptors
-
X. S. Wang and H. Y. A. Lau, "Prostaglandin E2 potentiates the immunologically stimulated histamine release from human peripheral blood-derived mast cells through EP1/EP3 receptors," Allergy: European Journal of Allergy and Clinical Immunology, Vol. 61, no. 4, pp. 503-506, 2006.
-
(2006)
Allergy: European Journal of Allergy and Clinical Immunology
, vol.61
, Issue.4
, pp. 503-506
-
-
Wang, X.S.1
Lau, H.Y.A.2
-
68
-
-
34547444931
-
2 receptor 3
-
2 receptor 3," Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, no. 28, pp. 11712-11717, 2007.
-
(2007)
Proceedings of the National Academy of Sciences of the United States of America
, vol.104
, Issue.28
, pp. 11712-11717
-
-
Weller, C.L.1
Collington, S.J.2
Hartnell, A.3
-
69
-
-
73749088151
-
Prostaglandin E2 at new glance: Novel insights in functional diversity offer therapeutic chances
-
D. F. Legler, M. Bruckner, E. Uetz-von Allmen, and P. Krause, "Prostaglandin E2 at new glance: Novel insights in functional diversity offer therapeutic chances," International Journal of Biochemistry and Cell Biology, Vol. 42, no. 2, pp. 198-201, 2010.
-
(2010)
International Journal of Biochemistry and Cell Biology
, vol.42
, Issue.2
, pp. 198-201
-
-
Legler, D.F.1
Bruckner, M.2
Uetz-Von Allmen, E.3
Krause, P.4
-
70
-
-
65449160912
-
Endothelial dysfunction and vascular disease
-
P. M. Vanhoutte, H. Shimokawa, E. H. C. Tang, and M. Feletou, "Endothelial dysfunction and vascular disease," Acta Physiologica, Vol. 196, no. 2, pp. 193-222, 2009.
-
(2009)
Acta Physiologica
, vol.196
, Issue.2
, pp. 193-222
-
-
Vanhoutte, P.M.1
Shimokawa, H.2
Tang, E.H.C.3
Feletou, M.4
-
71
-
-
67651166598
-
COX-1 and vascular disease
-
P. M. Vanhoutte, "COX-1 and vascular disease," Clinical Pharmacology and Therapeutics, Vol. 86, no. 2, pp. 212-215, 2009.
-
(2009)
Clinical Pharmacology and Therapeutics
, vol.86
, Issue.2
, pp. 212-215
-
-
Vanhoutte, P.M.1
-
72
-
-
77951755914
-
Prostacyclin in vascular diseases - Recent insights and future perspectives
-
J.-I. Kawabe, F. Ushikubi, and N. Hasebe, "Prostacyclin in vascular diseases - recent insights and future perspectives," Circulation Journal, Vol. 74, no. 5, pp. 836-843, 2010.
-
(2010)
Circulation Journal
, vol.74
, Issue.5
, pp. 836-843
-
-
Kawabe, J.-I.1
Ushikubi, F.2
Hasebe, N.3
-
73
-
-
84872528212
-
COX-2-derived prostaglandins do not contribute to coronary flow regulation in diabetic rats: Distinct secretion patterns of PGI2 and PGE 2
-
T. Przygodzki, M. Talar, and C. Watala, "COX-2-derived prostaglandins do not contribute to coronary flow regulation in diabetic rats: distinct secretion patterns of PGI2 and PGE 2," European Journal of Pharmacology, Vol. 700, no. 1-3, pp. 86-92, 2013.
-
(2013)
European Journal of Pharmacology
, vol.700
, Issue.1-3
, pp. 86-92
-
-
Przygodzki, T.1
Talar, M.2
Watala, C.3
-
74
-
-
48249090857
-
Renal hemodynamic effect of cyclooxygenase 2 inhibition in young men and women with uncomplicated type 1 Diabetes mellitus
-
D. Z. I. Cherney, J. W. Scholey, R. Nasrallah et al., "Renal hemodynamic effect of cyclooxygenase 2 inhibition in young men and women with uncomplicated type 1 Diabetes mellitus," American Journal of Physiology: Renal Physiology, Vol. 294, no. 6, pp. F1336-F1341, 2008.
-
(2008)
American Journal of Physiology: Renal Physiology
, vol.294
, Issue.6
, pp. F1336-F1341
-
-
Cherney, D.Z.I.1
Scholey, J.W.2
Nasrallah, R.3
-
75
-
-
0024500488
-
Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial
-
The Damad Study Group, "Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial," Diabetes, Vol. 38, no. 4, pp. 491-498, 1989.
-
(1989)
Diabetes
, vol.38
, Issue.4
, pp. 491-498
-
-
-
76
-
-
77949393585
-
Preliminary assessment of celecoxib and microdiode pulse laser treatment of diabetic macular edema
-
E. Y. Chew, J. Kim, H. R. Coleman et al., "Preliminary assessment of celecoxib and microdiode pulse laser treatment of diabetic macular edema," Retina, Vol. 30, no. 3, pp. 459-467, 2010.
-
(2010)
Retina
, vol.30
, Issue.3
, pp. 459-467
-
-
Chew, E.Y.1
Kim, J.2
Coleman, H.R.3
-
77
-
-
84870547618
-
Topical treatment for 1 week with latanoprost but not diclofenac reduces the diameter of dilated retinal arterioles in patients with type 1 diabetes mellitus and mild retinopathy
-
K. K. Tilma and T. Bek, "Topical treatment for 1 week with latanoprost but not diclofenac reduces the diameter of dilated retinal arterioles in patients with type 1 diabetes mellitus and mild retinopathy," Acta Ophthalmologica, Vol. 90, no. 8, pp. 750-755, 2012.
-
(2012)
Acta Ophthalmologica
, vol.90
, Issue.8
, pp. 750-755
-
-
Tilma, K.K.1
Bek, T.2
-
78
-
-
84873037534
-
Increased prostaglandin E2 (PGE2) levels in proliferative diabetic retinopathy, and correlation with VEGF and inflammatory cytokines
-
S. D. Schoenberger, S. J. Kim, J. Sheng, K. A. Rezaei, M. Lalezary, and E. Cherney, "Increased prostaglandin E2 (PGE2) levels in proliferative diabetic retinopathy, and correlation with VEGF and inflammatory cytokines," Investigative Ophthalmology & Visual Science, Vol. 53, no. 9, pp. 5906-5911, 2012.
-
(2012)
Investigative Ophthalmology & Visual Science
, vol.53
, Issue.9
, pp. 5906-5911
-
-
Schoenberger, S.D.1
Kim, S.J.2
Sheng, J.3
Rezaei, K.A.4
Lalezary, M.5
Cherney, E.6
-
79
-
-
84874979531
-
Elevated level of pro-inflammatory eicosanoids and EPC dysfunction in diabetic patients with cardiac ischemia
-
Y. Issana, E. Hochhausera, A. Guod et al., "Elevated level of pro-inflammatory eicosanoids and EPC dysfunction in diabetic patients with cardiac ischemia," Prostaglandins & Other Lipid Mediators, Vol. 100-101, pp. 15-21, 2013.
-
(2013)
Prostaglandins & Other Lipid Mediators
, vol.100-101
, pp. 15-21
-
-
Issana, Y.1
Hochhausera, E.2
Guod, A.3
-
80
-
-
0035039103
-
The role of gender in salt-induced hypertension
-
M.A. Bayorh, R.R. Socci, D. Eatman, M. Wang, and M. Thierry-Palmer, "The role of gender in salt-induced hypertension," Clinical and Experimental Hypertension, Vol. 23, no. 3, pp. 241-255, 2001.
-
(2001)
Clinical and Experimental Hypertension
, vol.23
, Issue.3
, pp. 241-255
-
-
Bayorh, M.A.1
Socci, R.R.2
Eatman, D.3
Wang, M.4
Thierry-Palmer, M.5
-
81
-
-
0034995077
-
Gender differences in the attenuation of salt-induced hypertension by angiotensin (1-7)
-
D. Eatman, M. Wang, R. R. Socci, M. Thierry-Palmer, N. Emmett, and M. A. Bayorh, "Gender differences in the attenuation of salt-induced hypertension by angiotensin (1-7)," Peptides, Vol. 22, no. 6, pp. 927-933, 2001.
-
(2001)
Peptides
, vol.22
, Issue.6
, pp. 927-933
-
-
Eatman, D.1
Wang, M.2
Socci, R.R.3
Thierry-Palmer, M.4
Emmett, N.5
Bayorh, M.A.6
-
82
-
-
0942265659
-
Gender, sex hormones, and vascular tone
-
J. M. Orshal and R. A. Khalil, "Gender, sex hormones, and vascular tone," The American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 286, no. 2, pp. R233-R249, 2004.
-
(2004)
The American Journal of Physiology - Regulatory Integrative and Comparative Physiology
, vol.286
, Issue.2
, pp. R233-R249
-
-
Orshal, J.M.1
Khalil, R.A.2
-
83
-
-
14644442966
-
Sexual dimorphism in renal production of prostanoids in spontaneously hypertensive rats
-
J. C. Sullivan, J. M. Sasser, D. M. Pollock, and J. S. Pollock, "Sexual dimorphism in renal production of prostanoids in spontaneously hypertensive rats," Hypertension, Vol. 45, no. 3, pp. 406-411, 2005.
-
(2005)
Hypertension
, vol.45
, Issue.3
, pp. 406-411
-
-
Sullivan, J.C.1
Sasser, J.M.2
Pollock, D.M.3
Pollock, J.S.4
-
84
-
-
84863727431
-
Prostaglandin e 2 and T cells: Friends or foes
-
V. Sreeramkumar, M. Fresno, and N. Cuesta, "Prostaglandin e 2 and T cells: friends or foes," Immunology and Cell Biology, Vol. 90, no. 6, pp. 579-586, 2012.
-
(2012)
Immunology and Cell Biology
, vol.90
, Issue.6
, pp. 579-586
-
-
Sreeramkumar, V.1
Fresno, M.2
Cuesta, N.3
-
85
-
-
84881040828
-
Chronic administration of EP4-selective agonist exacerbates albuminuria and fibrosis of the kidney in streptozotocin-induced diabetic mice through IL-6
-
R. Mohamed, C. Jayakumar, and G. Ramesh, "Chronic administration of EP4-selective agonist exacerbates albuminuria and fibrosis of the kidney in streptozotocin-induced diabetic mice through IL-6," Laboratory Investigation, Vol. 93, no. 8, pp. 933-945, 2013.
-
(2013)
Laboratory Investigation
, vol.93
, Issue.8
, pp. 933-945
-
-
Mohamed, R.1
Jayakumar, C.2
Ramesh, G.3
-
86
-
-
67650472199
-
Akita mice
-
Akita mice," American Journal of Nephrology, Vol. 30, no. 4, pp. 346-353, 2009.
-
(2009)
American Journal of Nephrology
, vol.30
, Issue.4
, pp. 346-353
-
-
Nasrallah, R.1
Robertson, S.J.2
Hébert, R.L.3
-
87
-
-
75749088574
-
2, an immunoactivator
-
2, an immunoactivator," Journal of Pharmacological Sciences, Vol. 112, no. 1, pp. 1-5, 2010.
-
(2010)
Journal of Pharmacological Sciences
, vol.112
, Issue.1
, pp. 1-5
-
-
Sakata, D.1
Yao, C.2
Narumiya, S.3
-
88
-
-
67349127266
-
Prostaglandin E2-EP4 signaling promotes immune inflammation through TH1 cell differentiation and TH17 cell expansion
-
C. Yao, D. Sakata, Y. Esaki et al., "Prostaglandin E2-EP4 signaling promotes immune inflammation through TH1 cell differentiation and TH17 cell expansion," Nature Medicine, Vol. 15, no. 6, pp. 633-640, 2009.
-
(2009)
Nature Medicine
, vol.15
, Issue.6
, pp. 633-640
-
-
Yao, C.1
Sakata, D.2
Esaki, Y.3
-
89
-
-
55749116154
-
2 synergistically with interleukin-23 favors human Th17 expansion
-
2 synergistically with interleukin-23 favors human Th17 expansion," Blood, Vol. 112, no. 9, pp. 3696-3703, 2008.
-
(2008)
Blood
, vol.112
, Issue.9
, pp. 3696-3703
-
-
Chizzolini, C.1
Chicheportiche, R.2
Alvarez, M.3
-
90
-
-
77951692935
-
A novel antagonist of the prostaglandin E 2 EP 4 receptor inhibits Th1 differentiation and Th17 expansion and is orally active in arthritis models
-
Q. Chen, K. Muramoto, N. Masaaki et al., "A novel antagonist of the prostaglandin E 2 EP 4 receptor inhibits Th1 differentiation and Th17 expansion and is orally active in arthritis models," British Journal of Pharmacology, Vol. 160, no. 2, pp. 292-310, 2010.
-
(2010)
British Journal of Pharmacology
, vol.160
, Issue.2
, pp. 292-310
-
-
Chen, Q.1
Muramoto, K.2
Masaaki, N.3
-
91
-
-
0034128995
-
A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats
-
J. L. Wang, H. F. Cheng, S. Shappell, and R. C. Harris, "A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats," Kidney International, Vol. 57, no. 6, pp. 2334-2342, 2000.
-
(2000)
Kidney International
, vol.57
, Issue.6
, pp. 2334-2342
-
-
Wang, J.L.1
Cheng, H.F.2
Shappell, S.3
Harris, R.C.4
-
92
-
-
80053217573
-
Therapeutic effect of prostaglandin E1 on diabetic nephropathy: A one-year follow-up study
-
(Chinese)
-
P.-F. Li, Y.-R. Mu, Y. Xin, Y. Qu, and L. Liao, "Therapeutic effect of prostaglandin E1 on diabetic nephropathy: a one-year follow-up study," Journal of Southern Medical University, Vol. 30, no. 3, pp. 482-485, 2010 (Chinese).
-
(2010)
Journal of Southern Medical University
, vol.30
, Issue.3
, pp. 482-485
-
-
Li, P.-F.1
Mu, Y.-R.2
Xin, Y.3
Qu, Y.4
Liao, L.5
-
93
-
-
0036517850
-
Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-α suppression
-
A. M. Joussen, V. Poulaki, N. Mitsiades et al., "Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-α suppression," The FASEB Journal, Vol. 16, no. 3, pp. 438-440, 2002.
-
(2002)
The FASEB Journal
, vol.16
, Issue.3
, pp. 438-440
-
-
Joussen, A.M.1
Poulaki, V.2
Mitsiades, N.3
-
94
-
-
78049283701
-
Angiogenic and inflammatory markers in the intraocular fluid of eyes with diabetic macular edema and influence of therapy with bevacizumab
-
M. Funk, G. Schmidinger, N. Maar et al., "Angiogenic and inflammatory markers in the intraocular fluid of eyes with diabetic macular edema and influence of therapy with bevacizumab," Retina, Vol. 30, no. 9, pp. 1412-1419, 2010.
-
(2010)
Retina
, vol.30
, Issue.9
, pp. 1412-1419
-
-
Funk, M.1
Schmidinger, G.2
Maar, N.3
-
95
-
-
17644418810
-
Prostaglandin E2 induces interleukin-8 gene transcription by activating C/EBP homologous protein in human T lymphocytes
-
S. Caristi, G. Piraino, M. Cucinotta, A. Valenti, S. Loddo, and D. Teti, "Prostaglandin E2 induces interleukin-8 gene transcription by activating C/EBP homologous protein in human T lymphocytes," Journal of Biological Chemistry, Vol. 280, no. 15, pp. 14433-14442, 2005.
-
(2005)
Journal of Biological Chemistry
, vol.280
, Issue.15
, pp. 14433-14442
-
-
Caristi, S.1
Piraino, G.2
Cucinotta, M.3
Valenti, A.4
Loddo, S.5
Teti, D.6
-
96
-
-
0031452740
-
Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: Immunochemical and in-situ hybridization-analyses
-
V. M. Elner, M. A. Burnstine, R. M. Strieter, S. L. Kunkel, and S. G. Elner, "Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: immunochemical and in-situ hybridization-analyses," Experimental Eye Research, Vol. 65, no. 6, pp. 781-789, 1997.
-
(1997)
Experimental Eye Research
, vol.65
, Issue.6
, pp. 781-789
-
-
Elner, V.M.1
Burnstine, M.A.2
Strieter, R.M.3
Kunkel, S.L.4
Elner, S.G.5
-
97
-
-
84892756877
-
Reduction of interleukin 8 and platelet-derived growth factor levels by topical ketorolac, 0.45%, in patients with diabetic retinopathy
-
S. D. Schoenberger, S. J. Kim, R. Shah, J. Sheng, and E. Cherney, "Reduction of interleukin 8 and platelet-derived growth factor levels by topical ketorolac, 0.45%, in patients with diabetic retinopathy," JAMA Ophthalmology, Vol. 132, no. 1, pp. 32-37, 2014.
-
(2014)
JAMA Ophthalmology
, vol.132
, Issue.1
, pp. 32-37
-
-
Schoenberger, S.D.1
Kim, S.J.2
Shah, R.3
Sheng, J.4
Cherney, E.5
-
98
-
-
6344284095
-
Retinal delivery of celecoxib is several-fold higher following subconjunctival administration compared to systemic administration
-
S. P. Ayalasomayajula and U. B. Kompella, "Retinal delivery of celecoxib is several-fold higher following subconjunctival administration compared to systemic administration," Pharmaceutical Research, Vol. 21, no. 10, pp. 1797-1804, 2004.
-
(2004)
Pharmaceutical Research
, vol.21
, Issue.10
, pp. 1797-1804
-
-
Ayalasomayajula, S.P.1
Kompella, U.B.2
-
99
-
-
0028938598
-
Pharmacodynamic profile of prostacyclin
-
J. R. Vane and R. M. Botting, "Pharmacodynamic profile of prostacyclin," American Journal of Cardiology, Vol. 75, no. 3, pp. 3A-10A, 1995.
-
(1995)
American Journal of Cardiology
, vol.75
, Issue.3
, pp. 3A-10A
-
-
Vane, J.R.1
Botting, R.M.2
-
100
-
-
0030447568
-
Platelet-aggregation inhibition and hemodynamic effects of beraprost sodium, a new oval prostacyclin derivative: A study in healthy male subjects
-
P. Nony, P. Ffrench, P. Girard et al., "Platelet-aggregation inhibition and hemodynamic effects of beraprost sodium, a new oval prostacyclin derivative: a study in healthy male subjects," Canadian Journal of Physiology and Pharmacology, Vol. 74, no. 8, pp. 887-893, 1996.
-
(1996)
Canadian Journal of Physiology and Pharmacology
, vol.74
, Issue.8
, pp. 887-893
-
-
Nony, P.1
Ffrench, P.2
Girard, P.3
-
101
-
-
0027517536
-
Pharmacokinetics and platelet antiaggregating effects of beraprost, an oral stable prostacyclin analogue, in healthy volunteers
-
J.-L. Demolis, A. Robert, M. Mouren, C. Funck-Brentano, and P. Jaillon, "Pharmacokinetics and platelet antiaggregating effects of beraprost, an oral stable prostacyclin analogue, in healthy volunteers," Journal of Cardiovascular Pharmacology, Vol. 22, no. 5, pp. 711-716, 1993.
-
(1993)
Journal of Cardiovascular Pharmacology
, vol.22
, Issue.5
, pp. 711-716
-
-
Demolis, J.-L.1
Robert, A.2
Mouren, M.3
Funck-Brentano, C.4
Jaillon, P.5
-
102
-
-
84878156565
-
Effects of Beraprost Sodium on subjective symptoms in diabetic patients with peripheral arterial disease
-
H. S. Yoon, W. J. Choi, I. H. Sung, H. S. Lee, H. J. Chung, and J. W. Lee, "Effects of Beraprost Sodium on subjective symptoms in diabetic patients with peripheral arterial disease," Clinics in Orthopedic Surgery, Vol. 5, no. 2, pp. 145-151, 2013.
-
(2013)
Clinics in Orthopedic Surgery
, vol.5
, Issue.2
, pp. 145-151
-
-
Yoon, H.S.1
Choi, W.J.2
Sung, I.H.3
Lee, H.S.4
Chung, H.J.5
Lee, J.W.6
-
103
-
-
84871937278
-
The effect of oral prostaglandin analogue on painful diabetic neuropathy: A double-blind, randomized, controlled trial
-
S. Shin, K. J. Kim, H.-J. Chang et al., "The effect of oral prostaglandin analogue on painful diabetic neuropathy: a double-blind, randomized, controlled trial," Diabetes, Obesity and Metabolism, Vol. 15, no. 2, pp. 185-188, 2013.
-
(2013)
Diabetes, Obesity and Metabolism
, vol.15
, Issue.2
, pp. 185-188
-
-
Shin, S.1
Kim, K.J.2
Chang, H.-J.3
|